Navigation Links
Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin
Date:2/14/2013

JERUSALEM, February 14, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in communication with the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application for oral insulin. The FDA has asked Oramed to perform a sub study in a controlled in-patient setting for up to a one-week period. In order to accommodate the FDA's request, Oramed will submit a new IND with a clinical protocol for the aforementioned sub study.

"We are very pleased to be in close and positive communications with the FDA, as well as having a clear path which meets the FDA's input. This positions us for imminent clearance from the FDA to proceed with our planned clinical studies," commented Nadav Kidron , CEO of Oramed.  

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's technology is based on over 30 years of research by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801) currently approaching Phase 2 clinical trials under U.S. IND, and with its oral exenatide capsule (ORMD-0901; a GLP-1 analog), currently approaching Phase 2a trials. The company's corporate and R&D headquarters are based in Jerusalem.

For more information, the content of which is not part of this press release, please visit  http://www.oramed.com
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bioassociate Announces Initiation of Coverage on Oramed Pharmaceuticals, Inc.
2. Oramed Pharmaceuticals Announces Reverse Stock Split
3. Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins
4. Auxilium Pharmaceuticals, Inc. to Present at the Leerink Swann Global Healthcare Conference
5. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Results and Conduct Conference Call on Tuesday, February 26, 2013
6. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
7. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
8. Todays Research on Mylan and Watson Pharmaceuticals: One Drug Makers Sorrow is Another Ones Joy
9. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
10. UPM Pharmaceuticals Enhances its Pre-Formulation Capabilities
11. Biosim Pharmaceuticals, Manufacturers of Generic ACTHAR, to Participate at Biotech Showcase 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... and LONDON , April 1, ... reports and solutions, MarketResearch.com is pleased to highlight a report ... year of market growth and opportunity for the stem cell ... or cord blood bank, competing in the stem cell marketplace ... industry trends, and act on market changes before the competition. ...
(Date:4/1/2015)... 1, 2015 Immunocore Limited ... biological drugs to treat cancer, viral infections and ... appointment of Christina Coughlin as Chief ... providing medical and regulatory leadership to the pre-clinical ... Dr. Coughlin has extensive experience in oncology drug ...
(Date:3/31/2015)... Eastern Kentucky University is ranked ... of criminal justice degree programs by Nonprofitcollegesonline.com. , ... ideas and high quality educational opportunities,” Editor Liz ... We are confident that students will find both ... the site’s first “Students before Profits” list, and ...
(Date:3/31/2015)... , March 31, 2015  Bayer HealthCare (Bayer) ... of Massachusetts Institute of Technology (MIT) and Harvard ... The goal of this new part of the ... to help create new cardiovascular therapies. ... the Broad Institute to the area of cardiovascular ...
Breaking Biology Technology:MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 2Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 3Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 4EKU Ranked in Top 50 Among Online Criminal Justice Degrees 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 3
... University have unraveled the mystery of how microbes generate ... metals. Details of the process, which can be ... of the Proceedings of the National Academy of ... changed by nuclear contamination, said Gemma Reguera, MSU microbiologist. ...
... - Researchers are making progress in creating digital transistors ... thought to dramatically limit the material,s use in computers ... of carbon that conducts electricity with little resistance or ... earned a Nobel Prize in physics - it was ...
... CORDOVA, Calif., Sept. 6, 2011 ThermoGenesis Corp. (NASDAQ: ... process and store adult stem cells, announced today it will report ... June 30, 2011, on Monday, September 12, 2011. ... will host a conference call Monday, September 12, 2011 at 2:00 ...
Cached Biology Technology:Microbes generate electricity while cleaning up nuclear waste 2Innovation is step toward digital graphene transistors 2ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2011 on September 12, 2011 2
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces its biometric ... news clip that aired this week on Washington ... In a segment "The Next Great Thing", host ... new way to pay, and ,a really big breakthrough in ...
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/17/2015)... March 17, 2015  MecklerMedia Corporation (OTCQX: MECK) ... for service robots ever held in ... on May 11-13, 2015 at the Javits Convention ... the event include: Acorn Product Development; Axis NJ; ... Kinova Robotics; Littler; NewBotic Corporation; Neya Systems LLC; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... led by researchers in the US and South Africa ... drug resistant (XDR) strain of the bacterium Mycobacterium tuberculosis, ... recent tuberculosis (TB) outbreak in KwaZulu-Natal, South Africa. As ... and drug sensitive isolates were also decoded. Initial comparisons ...
... diet available from the nutrient-poor soils in which they ... arthropods. Pitcher plants of the genus Nepenthes were thought ... but in a paper in this weeks PLoS ONE, ... physicist from the CNRS, working respectively in the University ...
... using coal are set to double by 2030, the scale of ... In view of the essential role of coal in Chinas ... used. The British Geological Survey (BGS) attended the ... in Beijing, China today. The aim of this study is to ...
Cached Biology News:Scientists decode genomes of diverse TB isolates 2Scientists decode genomes of diverse TB isolates 3Scientists decode genomes of diverse TB isolates 4Carnivorous plants use pitchers of 'slimy saliva' to catch their prey 2UK scientists lead China closer to carbon capture and storage 2